Login / Signup

Two cases of diabetes mellitus type 1 after alemtuzumab treatment for multiple sclerosis: another probable secondary autoimmune disease.

Stephan RichterBert WagnerElisabeth Gulowsen Celius
Published in: Journal of neurology (2019)
Keyphrases
  • multiple sclerosis
  • white matter
  • type diabetes
  • combination therapy
  • drug induced
  • glycemic control
  • weight loss
  • replacement therapy